|
|

 |
|
Targeted Genetics stock jumps on HIV data New York Times Shares of biotechnology company Targeted Genetics Corp. (TGEN.O) jumped 62 percent in pre-market trading on Friday after the company said its experimental HIV vaccine elicited a strong immune response in rabbits.
—Posted: June 7, 2003
More news headlines: This week | Last week | Search archive
|
|
|